Sanofi-Aventis (France) Study Finds Heart Rhythm Drug Cuts Stroke Risk by 1/3
BRIDGEWATER, N.J. - An experimental drug to treat irregular heart rhythm reduced the risk of stroke by one-third, according to data presented at the European Society of Cardiology conference Wednesday.